Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Teradyne director Marilyn Matz sold 800 shares of common stock on May 15, 2026, for a total value of $271,184. This transaction occurred while the company's shares had seen a decline over the past week but maintained a significant gain over the last year. Amid this insider activity, Teradyne announced key corporate actions and received varied analy…
The article details insider transactions by Teradyne's President and CEO, Gregory Smith, including the sale of company shares and the acquisition of stock via options. Furthermore, it provides an overview of recent corporate actions, such as a quarterly cash dividend announcement, alongside varied professional analysis covering long-term growth dri…
GrowGeneration Corp.'s CEO, Darren Lampert, recently acquired a significant block of the company's common stock. This transaction comes against a backdrop of the stock trading near its 52-week low while also showing recent momentum. Furthermore, the company reported Q1 2026 earnings, noting an increase in net sales despite operating with fewer phys…
Nexstar Media Group reported robust financial results for the first quarter of 2026, exceeding analyst expectations in both revenue and earnings per share. Concurrently, the company disclosed an insider transaction involving its President, which saw a significant sell-off of common stock. The firm also announced several key executive promotions.
Robert Johnson, President and CEO of Silicon Laboratories Inc., recently executed two separate transactions involving the sale of common stock. These sales occurred against a backdrop of significant corporate activity for SLAB, including an approved merger with Texas Instruments and key personnel appointments.
Duane Milton Pelkey, a director at Gouverneur Bancorp, Inc., recently purchased shares of the company's common stock. This transaction occurs as the stock trades near its 52-week high, coinciding with the announcement of a new semi-annual cash dividend. The filing details also outline Mr. Pelkey's existing holdings and derivative agreements related…
Luis de la Aguilera, President and CEO of USCB Financial Holdings, Inc., recently sold a total of 3,290 shares of the company's Class A Voting Common Stock across two transactions in mid-May. This occurred after he acquired an equal number of shares by exercising stock options. The sales took place while the stock was trading near its 52-week high.…
The Chief Financial Officer of Gladstone Investment Corporation, Ritchie Taylor, recently purchased a significant amount of the company's common stock through open market transactions. These purchases totaled $14,948 in shares acquired over several days in mid-May. This activity was reported via an SEC filing dated May 19, 2026. The article also no…
Executive Vice President and Chief Administrative Officer Barry H. Jensen increased his stake in Avidia Bancorp, Inc. (NASDAQ:AVBC) with a reported purchase of shares. This transaction occurred against a backdrop of positive financial performance, including an increase in net income for the first quarter of 2026 and the declaration of a quarterly c…
Horizon Kinetics Asset Management LLC, a major shareholder in Texas Pacific Land Corp (TPL), recently increased its direct holding in the company by purchasing additional common stock. This transaction occurred while TPL reported strong financial performance for the first quarter of 2026, surpassing both revenue and earnings expectations. Despite p…
Emily Yang, Senior Vice President of Worldwide Sales and Marketing at Diodes Inc. (NASDAQ:DIOD), executed a sale of company stock worth $202,930 on May 15, 2026. This transaction occurs against a backdrop of recent market volatility for the stock, although the company recently reported robust financial results and announced key leadership changes.
Brent Alexander Arriaga, a director at Riley Exploration Permian, Inc. (NASDAQ:REPX), recently conducted an open market sale of 2,500 shares of common stock valued at $97,350 on April 8, 2026. This transaction occurred while the stock was trading near its 52-week high of $41.26. The report also details a separate grant of restricted shares to Arria…
Joseph Stilwell, a significant shareholder and ten-percent owner of Peoples Financial Corp (PFBX), recently acquired an additional block of common stock. This transaction occurs while the stock is trading near its 52-week high and maintaining profitability metrics, though some analysts suggest it may be overvalued.
The recent sale of common stock by Dan Lanzano, President, National Advertising Sales at Nexstar Media Group Inc., was disclosed via an SEC Form 4 filing. This transaction occurs against a backdrop of positive corporate developments for Nexstar, including robust first-quarter financial reporting that exceeded market expectations and several key exe…
Director Peter Cannone III sold 1,350 shares of MKS INC common stock in a transaction valued at $409,590. This sale occurred despite the company's strong recent market performance, including a reported 237% return over the past year and a 106% surge within the last six months. Separately, MKS Instruments Inc. released first-quarter 2026 financial r…
A director at BCP Investment Corp (BCIC) recently sold a total of 15,000 shares valued at $114,667. This reported transaction occurred on May 18, 2026. Separately, the company released first-quarter financial results for 2026 that surpassed market expectations, reporting an earnings per share (EPS) of $0.55 against a forecast of $0.47 and revenue o…
Jason Ingersoll, Senior Vice President at Archrock, Inc., sold a substantial amount of company stock on May 18, 2026. This insider activity takes place while the company's shares are trading near their annual high and after recently reporting first-quarter financial results that missed analyst projections.
Donegal Mutual Insurance Co., a significant owner of Donegal Group Inc., recently increased its investment by acquiring 17,000 shares of Class A Common Stock. This transaction, which totaled approximately $293,182, occurred amidst market trading that has seen the stock decline over the last year. Separately, the company's annual shareholder meeting…
Japan Post Holdings Co., Ltd., a significant stakeholder in AFLAC INC (NASDAQ:AFL), reported the sale of approximately $2.75 million worth of common stock on May 15, 2026. This transaction occurred while AFLAC's stock traded near its 52-week high. In parallel corporate news, Aflac released its first-quarter 2026 earnings, reporting strong revenue g…
A key stakeholder in Lifeway Foods, Inc. recently sold a substantial amount of common stock. This transaction occurred against a backdrop of the company reporting strong first-quarter financial results that surpassed market expectations, even as an external brokerage downgraded its stock rating from Buy to Hold.
Gregg Williams, a director and ten percent owner of Vivani Medical, Inc. (NASDAQ:VANI), recently acquired over 1.5 million shares in a private transaction. This insider buying activity occurs while the company's current stock price and financial health metrics present mixed signals regarding its intrinsic value.
Genesis Energy LP (NASDAQ:GEL) Senior Vice President, Gaspard Garland, executed a significant purchase of company shares recently. This insider activity occurred against the backdrop of mixed financial results for the first quarter of 2026, where the company reported an EPS significantly below analyst expectations. The transaction and recent earnin…
The Chief Executive Officer of Orchestra BioMed Holdings, Inc., David P. Hochman, recently increased his personal investment in the company by purchasing 5,000 shares of common stock on May 15, 2026. This acquisition occurred while the stock was trading at $3.98, representing a 36% increase over the last year. The transaction contributed to Hochman…
Orchestra BioMed director Aryeh Jason recently increased his personal stake in the company, acquiring shares on May 15, 2026. This transaction occurred amidst several significant corporate developments, including price target adjustments from major financial institutions and announcements regarding advanced medical therapies.
Immunome director Jean Jacques Bienaime recently acquired a substantial block of the company's common stock, signaling internal confidence. This activity is coupled with positive developments regarding Immunome's drug candidate, varegacestat. The company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for treatin…
